Stay updated on Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial

Sign up to get notified when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The latest version updates core study details including recruitment status, study status, study design, and contact/locations. This affects how users track trial progress and locate study sites.
    Difference
    0.1%
    Check dated 2025-11-03T13:17:43.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Major update to page content reflecting current operating status and a version bump to v3.2.0; removes the old v3.1.0 reference.
    Difference
    13%
    Check dated 2025-10-06T04:14:06.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0, indicating a newer release.
    Difference
    0.3%
    Check dated 2025-09-28T23:35:11.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2 and the ‘Back to Top’ element was removed. Overall, these are minor UI/versioning changes with no impact on core content, pricing, availability, or scheduling.
    Difference
    0.8%
    Check dated 2025-09-14T09:53:50.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.8%
    Check dated 2025-09-07T07:53:35.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms have been removed.
    Difference
    7%
    Check dated 2025-08-31T01:00:28.000Z thumbnail image

Stay in the know with updates to Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.